Edgewell Reports 3% Q4 Sales Growth and Adjusted EPS of $0.78
Edgewell reported Q4 2026 net sales of $484.1M, up 3.0%, and adjusted EPS of $0.78. Full-year sales rose 1.8% to $1.997B, with adjusted EPS at $1.93. The company forecasted fiscal 2027 adjusted EPS of $1.85 to $2.15. Growth was driven by North America and International markets, with notable gains in Grooming and Sun and Skin Care segments.
How this was made
The 30-second read
Why it matters
The earnings beat and raised guidance provide a fresh catalyst for the stock, likely prompting short‑term buying.
Market read
First‑report earnings and guidance for a small‑cap consumer staple, offering a modest trading opportunity.
What to watch
Potential supply‑chain constraints in wet‑shave segment could temper growth.
Background
Edgewell Personal Care filed an 8‑K reporting Q4 2026 results and FY2027 guidance.
Ticker impact
Edgewell reported Q4 sales up 3% and raised FY2027 adjusted EPS guidance to $1.85‑$2.15 in its 8‑K filing.
modest upside as investors price in stronger guidance
Quarterly revenue beat and upward EPS guidance are fresh, material data for a small‑cap consumer company.
Market effects
May signal resilience in personal care consumer staples, supporting peers.
U.S. consumer discretionary sector could see slight lift.
Limited to U.S. small‑cap consumer segment.
Counterpoint
Guidance may be modest; market could already price in the beat, limiting upside.
Key entities
- companyEdgewell Personal Care Co
U.S. consumer personal care products manufacturer.
